PROVECTUS BIOPHARMACEUTICALS, INC. (DE)
PVCT
PVCT was delisted on the 13th of October, 2016.
6 hedge funds and large institutions have $13K invested in PROVECTUS BIOPHARMACEUTICALS, INC. (DE) in 2020 Q4 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.
20% more funds holding
Funds holding: 5 → 6 (+1)
19% less capital invested
Capital invested by funds: $16K → $13K (-$3K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAPTRUST Financial Advisors
Raleigh,
North Carolina
|
+$1K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
HFBOT
1
Home Federal Bank of Tennessee
Knoxville,
Tennessee
| $6K | – | – | – |
|
|
LDB
2
Lee, Danner & Bass
Nashville,
Tennessee
| $3K | – | – | – |
|
|
CCB
3
Cutter & Co Brokerage
Ballwin,
Missouri
| $2K | – | – | – |
|
|
ACM
4
Academy Capital Management
Waco,
Texas
| $1K | – | – | – |
|
|
5
CAPTRUST Financial Advisors
Raleigh,
North Carolina
| $1K | +$1K | +22,457 | New |
|
PVCT Hedge Fund Activity: Q4 2020 in Review
6 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in PROVECTUS BIOPHARMACEUTICALS, INC. (DE) (PVCT) for Q4 2020, worth a combined $13K — down 19% from $16K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new PVCT positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.
The largest buyer was CAPTRUST Financial Advisors, opening a new position worth an estimated $1K.
- 6 institutional investors held PROVECTUS BIOPHARMACEUTICALS, INC. (DE) (PVCT) as of Q4 2020, up from 5 in Q3 2020.
- Funds reported $13K of PROVECTUS BIOPHARMACEUTICALS, INC. (DE) stock for Q4 2020, down 19% quarter-over-quarter.
- 1 fund opened new PROVECTUS BIOPHARMACEUTICALS, INC. (DE) positions in Q4 2020 and 0 closed out, a net change of +1 holder.
- The largest PROVECTUS BIOPHARMACEUTICALS, INC. (DE) buyer in Q4 2020 was CAPTRUST Financial Advisors, an estimated $1K added.
Based on aggregated 13F filings for Q4 2020.